Assistant Professor, Radiation Oncology, University of Texas Southwestern Medical Center, Southwestern Medical School
Radiation Oncology
Dr. Kevin S. Choe, MD
|
|
Give Review
Kevin Choe is an expert in the field of Radiation Oncology. He graduated from Albert Einstein College of Medicine of Yeshiva University. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Kevin S. Choe, MD is also a published doctor. He has 18 paper published. The most recent paper is: Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgery. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Proton T2 measurement and quantification of lactate in brain tumors by MRS at 3 Tesla in vivo.
- A Retrospective Analysis of Tumor Volumetric Responses to Five-Fraction Stereotactic Radiotherapy for Paragangliomas of the Head and Neck (Glomus Tumors).
- Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.
- Molecular pathways and potential therapeutic targets in glioblastoma multiforme.
- Effects of aspirin on cancer initiation and progression.
- Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
- Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer.
- Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
- The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy.
- External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?
- PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells.
- Advances in radiotherapy for tumors involving the mediastinum.
- PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation.
- Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1.
- Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
- Radiotherapeutic strategies in the management of low-risk prostate cancer.
- Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgery.
Schools
Albert Einstein College of Medicine of Yeshiva University
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
Yale-New Haven Hospital -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
University of Texas Southwestern Medical Center -
Children's Health System of Texas -
Parkland Health & Hospital System -
Inova Fairfax Hospital
Drug Facts
| NPI NUMBER | 1609043892 | |
| NPPES Provider LastName | CHOE | |
| NPPES Provider FirstName | KEVIN | |
| NPPES Provider ZIPCode | 753907208 | |
| NPPES Provider State | TX | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 26.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609043892 |
| Last Name Of The Provider | CHOE |
| First Name Of The Provider | KEVIN |
| View All |
Similar Doctors
|
|
Dr. John K. O'Connor, MD |
|
|
Dr. Barry N. Wilcox, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hak Choy, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John Hyland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phuc D. Nguyen, MD |
|
|
Dr. Assal S. Rahimi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kesha R. Harris-Henderson, MD |
|
|
Dr. Chiachien J. Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberly M. Thomas, MD |